These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25490392)

  • 21. Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.
    Liu J; Wang Y; Li L; Zhou L; Wei H; Zhou Q; Liu J; Wang W; Ji L; Shan P; Wang Y; Yang Y; Jung SY; Zhang P; Wang C; Long W; Zhang B; Li X
    J Biol Chem; 2013 Jun; 288(23):16567-16578. PubMed ID: 23612972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
    Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
    EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells.
    Lu IF; Hasio AC; Hu MC; Yang FM; Su HM
    J Nutr Biochem; 2010 Jun; 21(6):512-7. PubMed ID: 19369047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.
    Vriend J; Reiter RJ
    Mol Cell Endocrinol; 2015 Dec; 417():1-9. PubMed ID: 26363225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
    Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
    Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer.
    Wang Q; Gao X; Yu T; Yuan L; Dai J; Wang W; Chen G; Jiao C; Zhou W; Huang Q; Cui L; Zhang P; Moses RE; Yang J; Chen F; Fu J; Xiao J; Li L; Dang Y; Li X
    Clin Cancer Res; 2018 Apr; 24(8):2015-2025. PubMed ID: 29437787
    [No Abstract]   [Full Text] [Related]  

  • 27. Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis.
    Xia X; Liao Y; Huang C; Liu Y; He J; Shao Z; Jiang L; Dou QP; Liu J; Huang H
    Cancer Lett; 2019 Nov; 465():118-128. PubMed ID: 31518603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of c-Myc protein stability by proteasome activator REGγ.
    Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P
    Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. REGγ is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells.
    Zhang M; Gan L; Ren GS
    Braz J Med Biol Res; 2012 May; 45(5):459-65. PubMed ID: 22415115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins.
    Li LP; Cheng WB; Li H; Li W; Yang H; Wen DH; Tang YD
    Asian Pac J Cancer Prev; 2012; 13(6):2699-703. PubMed ID: 22938444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.
    Lu R; Hu X; Zhou J; Sun J; Zhu AZ; Xu X; Zheng H; Gao X; Wang X; Jin H; Zhu P; Guo L
    Nat Commun; 2016 Jul; 7():12044. PubMed ID: 27375289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clomiphene citrate down-regulates estrogen receptor-α through the ubiquitin-proteasome pathway in a human endometrial cancer cell line.
    Amita M; Takahashi T; Igarashi H; Nagase S
    Mol Cell Endocrinol; 2016 Jun; 428():142-7. PubMed ID: 27033325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REGγ accelerates melanoma formation by regulating Wnt/β-catenin signalling pathway.
    Chen H; Gao X; Sun Z; Wang Q; Zuo D; Pan L; Li K; Chen J; Chen G; Hu K; Li K; Shah AS; Huang T; Muhammad Zeeshan B; Tong L; Jiao C; Liu J; Chen T; Yao L; Dang Y; Liu T; Li L
    Exp Dermatol; 2017 Nov; 26(11):1118-1124. PubMed ID: 28605165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway.
    Liu S; Zheng LL; Zhu YM; Shen HJ; Zhong Q; Huang J; Li C; Liu Z; Yao MD; Ou RM; Zhang Q
    Hematology; 2018 Jun; 23(5):277-283. PubMed ID: 29020881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells.
    Okuhira K; Demizu Y; Hattori T; Ohoka N; Shibata N; Nishimaki-Mogami T; Okuda H; Kurihara M; Naito M
    Cancer Sci; 2013 Nov; 104(11):1492-8. PubMed ID: 23992566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
    Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
    Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REG
    Zuo Q; Cheng S; Huang W; Bhatti MZ; Xue Y; Zhang Y; Zhang B; Li L; Wu L; Fu J; Chen J; Li X
    Oxid Med Cell Longev; 2017; 2017():7295319. PubMed ID: 28798860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth.
    Fallatah MM; Liu S; Sevigny MB; Zou H; Louie MC
    Cancer Lett; 2017 Nov; 408():82-91. PubMed ID: 28844711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.